Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Environ Toxicol Pharmacol ; 70: 103196, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31152944

RESUMEN

Antiparasitic substances are chemicals used to control or kill endoparasites and ectoparasites. Based on the premise that Ivermectin (IVM) and Amoxicillin (AMX) are commonly considered in parasitic control in mammals, the present study aimed to evaluate the carcinogenic and genotoxic potential of different concentrations of IVM and AMX through the detection of epithelial tumor test in Drosophila melanogaster. Third-instar larvae descending from the cross between wts/TM3, Sb1 females and mwh/mwh males were treated with different concentrations of IVM (2.9, 5.8, 11.6 and 23.2 x 10-17 mM) or AMX (1.37, 2.74, 5.48 and 10.9 x 10-16mM). The results revealed that IVM increased the frequency of epithelial tumor in D. melanogaster considering all evaluated concentrations, while AMX showed no carcinogenic effect. Furthermore, the Micronucleus (MN) test in Tradescantia pallida was used to evaluate the genotoxic effect of IVM and AMX. T. pallida individuals were exposed for 8 hours at different concentrations of IVM (5.71, 11.42, 22.84 and 45.68 x 10-5mM) or AMX (5.13, 10.26, 20.52 and 41.05 x 10-3mM). Findings showed an increase in the frequency of micronuclei in T. pallida treated with 11.42, 22.84 and 45.68 x 10-5mM of IVM. We conclude that chronic exposure to IVM is directly associated with events resulting from genetic instability (genotoxicity and carcinogenicity). On the other hand, AMX was neither carcinogenic nor genotoxic for D. melanogaster and T. pallida.


Asunto(s)
Amoxicilina/toxicidad , Antiparasitarios/toxicidad , Carcinógenos/toxicidad , Ivermectina/toxicidad , Mutágenos/toxicidad , Animales , Carcinoma/inducido químicamente , Daño del ADN , Drosophila melanogaster/efectos de los fármacos , Drosophila melanogaster/genética , Femenino , Larva/efectos de los fármacos , Larva/genética , Masculino , Pruebas de Mutagenicidad , Tradescantia/efectos de los fármacos , Tradescantia/genética
2.
Chemosphere ; 222: 503-510, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-30721808

RESUMEN

Spinosad (SPN) is a naturally-occurring insecticide obtained from the fermentation process of the actinomycete Saccharopolyspora spinosa. Owing to the larvicidal action, the compound has been used in the control of Aedes aegypti. As a new insecticide commercially available in the market, few data are reported on genotoxic effects in non-target organisms. The objective of the present study was to evaluate the mutagenic effect of SPN through the Micronucleus Test in Tradescantia pallida (Trad-MCN) and using the mutation and somatic recombination test in Drosophila melanogaster (SMART). At the Trad-MCN, after acclimatization (24 h), T. pallida stems were submitted to chronic treatment with SPN at concentrations of 0.156; 0.312; 0.625; 1.25 and 2.5 g/L solution for 24 h, followed by a recovery period. In SMART, considering the third stage larvae, offspring resulting from the ST and HB crossing were placed on chronic treatment (48 h) with 0.039; 0.078 and 0.156 µg/mL of SPN solution. No mutagenic effect was observed at any of the evaluated concentrations in SMART. Additionally, SPN is more toxic after metabolism via CYP6A2 (cytochrome P450) in D. melanogaster. However, SPN at the concentrations of 0.625; 1.25 and 2.5 g/L was able to induce high frequency of micronuclei in T. pallida. Under the experimental conditions of T. pallida in the present study, SPN caused genotoxic activity.


Asunto(s)
Drosophila melanogaster/efectos de los fármacos , Macrólidos/toxicidad , Pruebas de Mutagenicidad/métodos , Tradescantia/efectos de los fármacos , Animales , Proteínas de Drosophila , Drosophila melanogaster/genética , Combinación de Medicamentos , Femenino , Insecticidas/toxicidad , Larva/efectos de los fármacos , Masculino , Pruebas de Micronúcleos , Mutágenos/toxicidad , Tradescantia/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA